相关实验视频
Updated: Jun 20, 2026
08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
9.1K
癌症复发的形状:拓数据分析预测了儿科急性淋巴细胞白血病的复发情况
Salvador Chulián1,2,3, Bernadette J Stolz4,5, Álvaro Martínez-Rubio1,2,3
1Department of Mathematics, Universidad de Cádiz, Puerto Real (Cádiz), Spain.
PLoS computational biology
|August 14, 2023
概括
拓数据分析提高了急性淋巴细胞白血病 (ALL) 复发风险的预测. 这种方法与机器学习相结合,可以准确识别高风险患者,改进了传统的流细胞计评估.
科学领域:
- 血液学 血液学 血液学
- 计算生物学 计算生物学
- 数据科学数据科学数据科学
背景情况:
- 急性淋巴细胞白血病 (ALL) 的生存率很高,但15-20%的儿科患者出现复发.
- 目前的复发风险分层依赖于对高维流细胞计数据的手动评估,这是主观的.
- 现有的方法往往忽略了复杂的数据结构,如2D投影中的"空空间".
研究的目的:
- 应用拓数据分析 (TDA) 来更客观地评估ALL的流细胞计数据.
- 开发一种新的方法来预测使用无监督TDA和机器学习 (ML) 的ALL患者的复发风险.
- 在流细胞计数据中识别与患者结果相关的显著形状特征.
主要方法:
- 利用拓数据分析 (TDA) 来量化形状特征,包括"空空间",在预处理ALL流细胞计数据集.
- 结合无监督的TDA与机器学习 (ML) 算法来识别预测形状特征.
- 在四个参数空间内验证了特定生物标志物的预测能力 (CD10,CD20,CD38,CD45).
主要成果:
- 与ML结合的TDA准确地预测了ALL患者的复发风险,特别是最初被归类为"低风险"的患者.
- 这项研究证实了CD10,CD20,CD38和CD45生物标志物的预后价值.
- 提出了三层预测管道,用于流细胞计数据分析,从视觉检查到高级TDA-ML集成.
结论:
- TDA提供了一种强大,数据驱动的方法,以提高儿科ALL复发风险预测的准确性.
- 拟议的TDA-ML管道为风险分层提供了一种更客观,潜在更敏感的风险分层方法.
- 这种方法适用于分析其他血液性恶性瘤的流细胞计数据.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.4K
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...